Maxalt [rizatriptan] 10mg plus caffeine 75mg in the acute treatment of migraine headache.

Trial Profile

Maxalt [rizatriptan] 10mg plus caffeine 75mg in the acute treatment of migraine headache.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2012

At a glance

  • Drugs Caffeine; Rizatriptan
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Apr 2009 Results presented at AAN 2009.
    • 29 Jan 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top